Predictors of survival in patients with brain metastases from gastric cancer

D. Rades, T. Bartscht, S. E. Schild

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study aims to identify predictors of survival and contribute to treatment personalization in patients with brain metastases from gastric cancer. Twelve patients received whole-brain radiotherapy (WBRT), four stereotactic radiosurgery and six neurosurgery plus WBRT. Treatment regimen, age, gender, Eastern Cooperative Oncology Group (ECOG) performance score, tumor site, number of brain metastases, extra-cranial metastases and interval between cancer diagnosis and brain metastases were evaluated for survival. On univariate analyses, more intensive treatment (p=0.003), ECOG-score 0-1 (p<0.001), cardiac location (p=0.025) and single brain metastasis (p=0.023) were associated with better survival. On multivariate analysis, ECOG-score maintained significance (p<0.001). Patients with all three positive factors on univariate analysis had a 12-month survival rate of 100%, patients with three negative factors a 3-month survival rate of 0%. Predictors of survival were identified that can guide physicians selecting personalized treatment approaches for patients with brain metastases from gastric cancer.

Original languageEnglish (US)
Pages (from-to)136-139
Number of pages4
JournalNeoplasma
Volume64
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Stomach Neoplasms
Neoplasm Metastasis
Survival
Brain
Radiotherapy
Survival Rate
Radiosurgery
Neurosurgery
Therapeutics
Brain Neoplasms
Multivariate Analysis
Physicians
Neoplasms

Keywords

  • Brain metastases
  • Cardiac cancer
  • Gastric cancer
  • Radiotherapy
  • Survival

ASJC Scopus subject areas

  • Cancer Research

Cite this

Predictors of survival in patients with brain metastases from gastric cancer. / Rades, D.; Bartscht, T.; Schild, S. E.

In: Neoplasma, Vol. 64, No. 1, 2017, p. 136-139.

Research output: Contribution to journalArticle

Rades, D. ; Bartscht, T. ; Schild, S. E. / Predictors of survival in patients with brain metastases from gastric cancer. In: Neoplasma. 2017 ; Vol. 64, No. 1. pp. 136-139.
@article{2c91a54de4f641759ade6003a9a66c3d,
title = "Predictors of survival in patients with brain metastases from gastric cancer",
abstract = "This study aims to identify predictors of survival and contribute to treatment personalization in patients with brain metastases from gastric cancer. Twelve patients received whole-brain radiotherapy (WBRT), four stereotactic radiosurgery and six neurosurgery plus WBRT. Treatment regimen, age, gender, Eastern Cooperative Oncology Group (ECOG) performance score, tumor site, number of brain metastases, extra-cranial metastases and interval between cancer diagnosis and brain metastases were evaluated for survival. On univariate analyses, more intensive treatment (p=0.003), ECOG-score 0-1 (p<0.001), cardiac location (p=0.025) and single brain metastasis (p=0.023) were associated with better survival. On multivariate analysis, ECOG-score maintained significance (p<0.001). Patients with all three positive factors on univariate analysis had a 12-month survival rate of 100{\%}, patients with three negative factors a 3-month survival rate of 0{\%}. Predictors of survival were identified that can guide physicians selecting personalized treatment approaches for patients with brain metastases from gastric cancer.",
keywords = "Brain metastases, Cardiac cancer, Gastric cancer, Radiotherapy, Survival",
author = "D. Rades and T. Bartscht and Schild, {S. E.}",
year = "2017",
doi = "10.4149/neo_2017_117",
language = "English (US)",
volume = "64",
pages = "136--139",
journal = "Neoplasma",
issn = "0028-2685",
publisher = "Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences",
number = "1",

}

TY - JOUR

T1 - Predictors of survival in patients with brain metastases from gastric cancer

AU - Rades, D.

AU - Bartscht, T.

AU - Schild, S. E.

PY - 2017

Y1 - 2017

N2 - This study aims to identify predictors of survival and contribute to treatment personalization in patients with brain metastases from gastric cancer. Twelve patients received whole-brain radiotherapy (WBRT), four stereotactic radiosurgery and six neurosurgery plus WBRT. Treatment regimen, age, gender, Eastern Cooperative Oncology Group (ECOG) performance score, tumor site, number of brain metastases, extra-cranial metastases and interval between cancer diagnosis and brain metastases were evaluated for survival. On univariate analyses, more intensive treatment (p=0.003), ECOG-score 0-1 (p<0.001), cardiac location (p=0.025) and single brain metastasis (p=0.023) were associated with better survival. On multivariate analysis, ECOG-score maintained significance (p<0.001). Patients with all three positive factors on univariate analysis had a 12-month survival rate of 100%, patients with three negative factors a 3-month survival rate of 0%. Predictors of survival were identified that can guide physicians selecting personalized treatment approaches for patients with brain metastases from gastric cancer.

AB - This study aims to identify predictors of survival and contribute to treatment personalization in patients with brain metastases from gastric cancer. Twelve patients received whole-brain radiotherapy (WBRT), four stereotactic radiosurgery and six neurosurgery plus WBRT. Treatment regimen, age, gender, Eastern Cooperative Oncology Group (ECOG) performance score, tumor site, number of brain metastases, extra-cranial metastases and interval between cancer diagnosis and brain metastases were evaluated for survival. On univariate analyses, more intensive treatment (p=0.003), ECOG-score 0-1 (p<0.001), cardiac location (p=0.025) and single brain metastasis (p=0.023) were associated with better survival. On multivariate analysis, ECOG-score maintained significance (p<0.001). Patients with all three positive factors on univariate analysis had a 12-month survival rate of 100%, patients with three negative factors a 3-month survival rate of 0%. Predictors of survival were identified that can guide physicians selecting personalized treatment approaches for patients with brain metastases from gastric cancer.

KW - Brain metastases

KW - Cardiac cancer

KW - Gastric cancer

KW - Radiotherapy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85020449634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020449634&partnerID=8YFLogxK

U2 - 10.4149/neo_2017_117

DO - 10.4149/neo_2017_117

M3 - Article

VL - 64

SP - 136

EP - 139

JO - Neoplasma

JF - Neoplasma

SN - 0028-2685

IS - 1

ER -